377 related items for PubMed ID: 8984708
21. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
Derom E, Van De Velde V, Marissens S, Engelstätter R, Vincken W, Pauwels R.
Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
[Abstract] [Full Text] [Related]
22. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J.
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[Abstract] [Full Text] [Related]
23. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ.
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
[Abstract] [Full Text] [Related]
24. Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide.
Phillips K, Oborne J, Lewis S, Harrison TW, Tattersfield AE.
Thorax; 2004 Jan; 59(1):26-30. PubMed ID: 14694242
[Abstract] [Full Text] [Related]
25. Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults.
Wilson AM, Lipworth BJ.
Br J Clin Pharmacol; 1999 Oct; 48(4):579-85. PubMed ID: 10583029
[Abstract] [Full Text] [Related]
26. [Adrenal cortex function in children with bronchial asthma in fluticasone therapy].
Hoffmann-Streb A, L'Allemand D, Niggemann B, Büttner P, Wahn U.
Monatsschr Kinderheilkd; 1993 Jun; 141(6):508-12. PubMed ID: 8336748
[Abstract] [Full Text] [Related]
27. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
Kramer S, Rottier BL, Scholten RJ, Boluyt N.
Cochrane Database Syst Rev; 2013 Feb 28; (2):CD010352. PubMed ID: 23450613
[Abstract] [Full Text] [Related]
28. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
Dempsey OJ, Wilson AM, Coutie WJ, Lipworth BJ.
Chest; 1999 Oct 28; 116(4):935-40. PubMed ID: 10531156
[Abstract] [Full Text] [Related]
29. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB.
Ann Allergy Asthma Immunol; 2001 Nov 28; 87(5):379-85. PubMed ID: 11730179
[Abstract] [Full Text] [Related]
30. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
Respir Med; 2000 May 28; 94(5):482-9. PubMed ID: 10868712
[Abstract] [Full Text] [Related]
31. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
Am J Respir Crit Care Med; 1999 Jul 28; 160(1):157-61. PubMed ID: 10390394
[Abstract] [Full Text] [Related]
32. Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment.
Wilson AM, Sims EJ, Lipworth BJ.
Clin Endocrinol (Oxf); 1999 Mar 28; 50(3):329-35. PubMed ID: 10435058
[Abstract] [Full Text] [Related]
33. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A.
Lancet; 2000 Aug 12; 356(9229):556-61. PubMed ID: 10950233
[Abstract] [Full Text] [Related]
34. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.
Selroos O, Halme M.
Thorax; 1991 Dec 12; 46(12):891-4. PubMed ID: 1792636
[Abstract] [Full Text] [Related]
35. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
Dyer MJ, Halpin DM, Stein K.
BMC Fam Pract; 2006 Jun 05; 7():34. PubMed ID: 16753053
[Abstract] [Full Text] [Related]
36. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
Chest; 2005 Mar 05; 127(3):851-60. PubMed ID: 15764767
[Abstract] [Full Text] [Related]
37. Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers.
Dempsey OJ, Humphreys M, Coutie WJ, Lipworth BJ.
Eur J Clin Pharmacol; 2001 Nov 05; 57(9):637-41. PubMed ID: 11791892
[Abstract] [Full Text] [Related]
38. Assessment of the relative systemic potency of inhaled fluticasone and budesonide.
Boorsma M, Andersson N, Larsson P, Ullman A.
Eur Respir J; 1996 Jul 05; 9(7):1427-32. PubMed ID: 8836654
[Abstract] [Full Text] [Related]
39. Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects.
Harrison TW, Tattersfield AE.
Thorax; 2003 Mar 05; 58(3):258-60. PubMed ID: 12612308
[Abstract] [Full Text] [Related]
40. Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate.
Dempsey OJ, Coutie WJ, Wilson AM, Williams P, Lipworth BJ.
Thorax; 1999 Jul 05; 54(7):614-7. PubMed ID: 10377207
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
